Reduced risk of chronic GVHD by low-dose rATG in adult matched sibling donor peripheral blood stem cell transplantation for hematologic malignancies
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Hematology"
DOI: 10.1007/s00277-019-03884-8
Abstract: The optimal rabbit anti-thymocyte globulin (rATG) graft-versus-host disease (GVHD) prophylaxis regimen in matched sibling donor peripheral blood stem cell transplantation (MSD-PBSCT) remains to be elucidated. In this prospective study, we used low-dose rATG for GVHD… read more here.
Keywords: ratg; transplantation; sibling donor; gvhd ... See more keywords
Low-Dose Antithymocyte Globulin Has No Disadvantages to Standard Higher Dose in Pediatric Kidney Transplant Recipients: Report From the Pediatric Nephrology Research Consortium
Sign Up to like & getrecommendations! Published in 2021 at "Kidney International Reports"
DOI: 10.1016/j.ekir.2021.01.007
Abstract: Introduction Rabbit antithymocyte globulin (rATG) dosing strategies for induction in pediatric kidney transplantation vary between centers. It is not known whether a lower rATG induction dose provides safe and effective immunosuppression compared with a “standard”… read more here.
Keywords: nephrology; induction; dose; pediatric kidney ... See more keywords
The Optimal Cumulative Dose of Rabbit Antithymocyte Globulin Induction in Adult Heart Transplantation
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Heart and Lung Transplantation"
DOI: 10.1016/j.healun.2021.01.418
Abstract: Purpose To determine the optimal cumulative dose of rabbit antithymocyte globulin (rATG) regarding its efficacy and safety and to evaluate the target level of CD3+ T cell count for induction therapy in adult heart transplantation.… read more here.
Keywords: cumulative dose; ratg; dose; heart transplantation ... See more keywords
Association between cumulative rATG induction doses and kidney graft outcomes and adverse effects in kidney transplant patients: a systematic review and meta-analysis
Sign Up to like & getrecommendations! Published in 2021 at "Expert Opinion on Biological Therapy"
DOI: 10.1080/14712598.2021.1960978
Abstract: ABSTRACT Background This systematic review and meta-analysis were performed to explore the association between rabbit thymoglobulin (rATG) doses and transplant-related efficacy and safety outcomes. Methods We searched PubMed and Scopus databases from inception up to… read more here.
Keywords: review meta; kidney transplant; systematic review; ratg ... See more keywords
Rabbit Antithymocyte Globulin for Treatment of Corticosteroid Refractory Acute Cellular Rejection After Lung Transplantation.
Sign Up to like & getrecommendations! Published in 2023 at "Transplantation"
DOI: 10.1097/tp.0000000000004617
Abstract: BACKGROUND Chronic lung allograft dysfunction (CLAD) remains a major cause of death after the first year posttransplant, with acute cellular rejection (ACR) being a major risk factor for CLAD. We evaluated the use of rabbit… read more here.
Keywords: refractory; acr; acute cellular; lung ... See more keywords
The Efficacy of Rabbit Anti-Thymocyte Globulin for Acute Kidney Transplant Rejection in Patients Using Calcineurin Inhibitor and Mycophenolate Mofetil-Based Immunosuppressive Therapy
Sign Up to like & getrecommendations! Published in 2018 at "Annals of Transplantation"
DOI: 10.12659/aot.909646
Abstract: Background T cell depleting antibody therapy with rabbit anti-thymocyte globulin (rATG) is the treatment of choice for glucocorticoid-resistant acute kidney allograft rejection (AR) and is used as first-line therapy in severe AR. Almost all studies… read more here.
Keywords: immunosuppressive therapy; rejection; patients using; ratg ... See more keywords